Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Recurrent Diarrhea Clinical Trials

A listing of Recurrent Diarrhea medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (9) clinical trials

Wake Research Associates is enrolling volunteers with C. Diff in a study testing the effectiveness, tolerability and safety of an investigational medication for this condition. Some of the symptoms of C. diff infection include: Watery diarrhea, up to 15 times each day Severe abdominal pain Loss of appetite Fever Blood ...

Phase N/A

If you've tried Imodium and are still experiencing symptoms of abdominal pain and diarrhea, learn how you could be eligible to participate in a research study of an approved drug for Irritable Bowel Syndrome with diarrhea (IBS-D).

Phase

A research study is evaluating an investigational medication for adults with recurrent Clostridium difficile (C. diff) infection. The study is seeking to find out if the study medication helps reduce the risk of recurring infections.  

Phase N/A

Are you or a loved one suffering from the abdominal (belly) pain and discomfort, abnormal bowel habits, and bloating of Irritable Bowel Syndrome with Diarrhea (IBS-D)? Right now, clinical research doctors are seeking volunteers for an investigational drug study in your area to learn how it affects people with IBS-D. ...

Phase

The purpose of this study is to assess safety and efficacy of study medication in reducing recurrence of Clostridium Difficile Infection (CDI) in adults who had a CDI recurrence.

Phase N/A

ECOSPOR III is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the safety, tolerability, and efficacy of SER-109 versus placebo in adult subjects 18 years of age or older with recurrent CDI, defined as: a history of ≥ 3 CDI episodes within 9 months, inclusive of the current ...

Phase

Fludarabine Phosphate Cyclophosphamide Total Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

PRIMARY OBJECTIVES: I. To evaluate the rate of relapse, defined as recurrence of underlying disease or progression of underlying disease, at 1 year in patients who receive haploidentical peripheral blood stem cells (PBSCs) after reduced intensity conditioning and post-transplant cyclophosphamide. SECONDARY OBJECTIVES: I. To evaluate safety including development of acute ...

Phase

Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection

This prospective double blind randomized study will enroll 110 patients with recurrent Clostridium difficile infection (RCDI) in a 1:1 ratio to receive either LFMT or LSFF by capsules. Patients will receive 15 capsules at week 0 and be assessed at weeks 1, 4, 8 and 24. Blood, stool and urine ...

Phase

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

PRIMARY OBJECTIVES: I. To assess the efficacy as measured by the confirmed overall hematologic response rate (partial response or better) of isatuximab in relapsed/refractory systemic light chain (AL) amyloidosis. SECONDARY OBJECTIVES: I. To evaluate toxicities in the treatment of relapsed/refractory AL amyloidosis with isatuximab. II. To evaluate time to hematologic ...

Phase